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Abstract
Objective:  This  study  aimed  to  investigate  the  relationship  between  circulating  endothelial
progenitor  cell  count  and  endothelial  activation  in  a  pediatric  population  with  obesity.
Methods: Observational  and  transversal  study,  including  120  children  and  adolescents  with
primary obesity  of  both  sexes,  aged  6--17  years,  who  were  recruited  at  this  Cardiovascular
Risk Clinic.  The  control  group  was  made  up  of  41  children  and  adolescents  with  normal  body
mass index.  The  variables  analyzed  were:  age,  gender,  body  mass  index,  systolic  and  diastolicAsymmetric blood pressure,  high-sensitivity  C-reactive  protein,  lipid  proﬁle,  leptin,  adiponectin,  homeo-
dimethylarginine; stasis model  assessment-insulin  resistance,  monocyte  chemoattractant  protein-1,  E-selectin,
Endothelial
progenitor  cells
asymmetric  dimethylarginine  and  circulating  progenitor  endothelial  cell  count.
 Please cite this article as: Pires A, Martins P, Paiva A, Pereira AM, Marques M, Castela E, et al. Circulating endothelial progenitor cells in
bese children and adolescents. J Pediatr (Rio J). 2015;91:560--6.
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Results:  Insulin  resistance  was  correlated  to  asymmetric  dimethylarginine  (  =  0.340;  p  =  0.003),
which was  directly,  but  weakly  correlated  to  E-selectin  (  =  0.252;  p  =  0.046).  High  sensitiv-
ity C-reactive  protein  was  not  found  to  be  correlated  to  markers  of  endothelial  activation.
Systolic  blood  pressure  was  directly  correlated  to  body  mass  index  (  =  0.471;  p  <  0.001)  and
the homeostasis  model  assessment-insulin  resistance  (  =  0.230;  p  =  0.012),  and  inversely  corre-
lated to  adiponectin  (  =  −0.331;  p  <  0.001)  and  high-density  lipoprotein  cholesterol  (  =  −0.319;
p <  0.001).  Circulating  endothelial  progenitor  cell  count  was  directly,  but  weakly  correlated,  to
body mass  index  (r  =  0.211;  p  =  0.016),  leptin  (  =  0.245;  p  =  0.006),  triglyceride  levels  (r  =  0.241;
p =  0.031),  and  E-selectin  (  =  0.297;  p  =  0.004).
Conclusion:  Circulating  endothelial  progenitor  cell  count  is  elevated  in  obese  children  and  ado-
lescents  with  evidence  of  endothelial  activation,  suggesting  that,  during  infancy,  endothelial
repairing  mechanisms  are  present  in  the  context  of  endothelial  activation.
© 2015  Sociedade  Brasileira  de  Pediatria.  Published  by  Elsevier  Editora  Ltda.  All  rights  reserved.
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Células  progenitoras  endoteliais  circulantes  em  crianc¸as e  adolescentes  obesos
Resumo
Objetivo:  O  objetivo  deste  estudo  foi  investigar  a  relac¸ão  entre  os  números  de  células  pro-
genitoras  endoteliais  circulantes  e  a  ativac¸ão  endotelial  em  uma  populac¸ão  pediátrica  com
obesidade.
Métodos:  Estudo  observacional  e  transversal,  incluindo  120  crianc¸as  e  adolescentes  com  obesi-
dade primária  de  ambos  de  sexos,  com  idades  entre  6  e  17  anos,  recrutados  de  nossa  Clínica
de Riscos  Cardiovasculares.  O  grupo  de  controle  contou  com  41  crianc¸as  e  adolescentes  com
índice de  massa  corporal  normal.  As  variáveis  analisadas  foram:  idade,  sexo,  índice  de  massa
corporal, pressão  arterial  sistólica  e  diastólica,  proteína  C  reativa  de  alta  sensibilidade,  perﬁl
lipídico,  leptina,  adiponectina,  resistência  à  insulina  para  avaliac¸ão  do  modelo  de  homeostase,
proteína quimiotática  de  monócitos-1,  E-seleticna,  dimetilarginina  assimétrica  e  números  de
células endoteliais  progenitoras  circulantes.
Resultados:  A  resistência  à  insulina  foi  correlacionada  a  dimetilarginina  assimétrica  (p  =  0,340;
p =  0,003),  que  foi  diretamente  correlacionada,  porém  de  forma  muita  amena  à  E-seleticna
( =  0,252;  p  =  0,046).  Não  constatamos  que  a  proteína  C  reativa  de  alta  sensibilidade  está
correlacionada  a  marcadores  de  ativac¸ão  endotelial.  A  pressão  arterial  sistólica  foi  direta-
mente correlacionada  ao  índice  de  massa  corporal    =  0,471;  p  <  0,001)  e  à  resistência  à  insulina
para avaliac¸ão  do  modelo  de  homeostase  (  =  0,230;  p  =  0,012)  e  inversamente  correlacionada
a adiponectina  (  =  -0,331;  p  <  0,001)  e  lipoproteína  de  alta  densidade-colesterol    =  -0,319;
p <  0,001).  Os  números  de  células  progenitoras  endoteliais  circulantes  foram  diretamente  cor-
relacionados,  porém  de  forma  muito  amena  ao  índice  de  massa  corporal  (r  =  0,211;  p  =  0,016),
à leptina  (  =  0,245;  p  =  0,006),  aos  níveis  de  triglicerídeos  (r  =  0,241;  p  =  0,031)  e  à  E-seleticna
 =  0,297;  p  =  0,004).
Conclusão:  Os  números  de  células  progenitoras  endoteliais  circulantes  são  elevados  em  crianc¸as
e adolescentes  obesos  com  comprovac¸ão  de  ativac¸ão  endotelial,  sugerindo  que,  na  infância,  os
mecanismos  de  reparac¸ão  endotelial  estão  presentes  no  contexto  da  ativac¸ão  endotelial.
© 2015  Sociedade  Brasileira  de  Pediatria.  Publicado  por  Elsevier  Editora  Ltda.  Todos  os  direitos
reservados.
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In  obesity,  various  inﬂammatory  agents,  such  as  C-reactive
protein1--3 and  leptin,4 disturb  the  production  of  nitric  oxide
via  the  inhibition  of  its  rate-limiting  enzyme,  endothelial
nitric  oxide  synthase  (eNOS).5,6 Other  endogenous  sub-
stances,  such  as  asymmetric  dimethylarginine  (ADMA),  a
competitive  antagonist  of  eNOS,  also  play  a  role  in  fur-
ther  compromising  nitric  oxide  bioavailability.  Its  production
is  stimulated  by  inﬂammatory  agents,  such  as  C-reactive
e
arotein.7 Unlike  nitric  oxide,  it  can  be  easily  assayed  and
sed  as  a surrogate  for  nitric  oxide  bioavailability.
Damaged  endothelium  is  repaired  through  the  prolif-
ration  of  adjacent  endothelial  cells,  whose  regenerative
apacity  is  limited,  and  through  the  migration  of  progenitor
ells,  which  originate  in  the  bone  marrow,  known  as  cir-
ulating  endothelial  progenitor  cells  (EPCs).  They  express  a
ariety  of  cell  markers  similar  to  those  expressed  by  vascular
ndothelium,  which  display  vascular  regenerative  properties
nd,  as  such,  participate  in  new  vessel  formation.8
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In  patients  with  cardiovascular  risk  factors,  such  as  arte-
ial  hypertension  and  insulin  resistance,  the  count  and
unction  of  EPCs  is  reduced.  In  these,  the  risk  of  cardio-
ascular  events  is  increased.9,10
Inﬂammatory  markers  also  appears  to  reduce  the  number
f  EPCs,  implying  a  possible  role  in  obesity.11,12
The  aims  of  the  present  study  were  two  fold.  Firstly,
o  demonstrate  that  endothelial  activation  is  present  in
hildhood  obesity;  and  secondly,  that  repairing  mechanisms,
hrough  EPC  activation,  are  not,  at  this  early  stage,  compro-
ised.
ethods
ubjects
he  authors  conducted  an  observational  and  transversal
nalysis,  in  a  cohort  of  obese  children  and  adolescents,
ecruited  randomly,  and  followed-up  at  a  Cardiovascular  Risk
linic.  All  parents  gave  their  informed  consent  for  the  chil-
ren  to  participate  in  the  study,  which  had  been  approved
y  the  local  Ethics  Committee.
The  inclusion  criteria  for  the  study  group  were  primary
besity  (body  mass  index  [BMI]  above  the  95th  percentile  for
ex  and  age)  in  children  and  adolescents  aged  6--17  years,
ithout  recent  or  chronic  illnesses.  The  exclusion  criteria
ncluded  secondary  causes  of  obesity,  acute  infectious  or
nﬂammatory  disorders  (within  a  month  of  sampling),  and
hronic  disorders.
The  control  group  included  healthy  children  and  adoles-
ents,  unrelated  to  the  study  group,  within  the  same  age
ange  with  a  normal  BMI  (percentil  5--85),  recruited  from
he  Cardiology  Clinic  where  they  were  sent  for  evaluation  of
urmurs,  but  proved  to  have  no  subjacent  cardiac  anoma-
ies.  All  had  undergone  a  12-h  fast  prior  to  the  clinical
valuation  and  blood  sampling.
The  study  group  comprised  120  and  the  control  group
1  children  and  adolescents,  of  both  sexes.  Based  on  this
ample  size,  a  signiﬁcance  level  (p-value)  of  0.05,  a  power
f  0.80,  and  an  effect  size  of  0.52  were  obtained.  These
alues  were  calculated  using  the  G*Power  3.1.5  program.
The  variables  analyzed  were:  age,  gender,  body  mass
ndex,  systolic  blood  pressure,  diastolic  blood  pressure,  total
holesterol,  high-density  lipoprotein  cholesterol  (HDL-C),
ow  density  lipoprotein  cholesterol  (LDL-C),  triglycerides,
igh-sensitivity  C-reactive  protein  (hsCRP),  monocyte
hemoattractant  protein-1  (MCP-1),  lipid  proﬁle,  leptin,
diponectin,  homeostasis  model  assessment-insulin  resis-
ance  (HOMA-IR),  E-selectin,  asymmetric  dimethylarginine,
nd  circulating  EPC  count.
linical  and  anthropometric  evaluation
eight  (in  kilograms  to  the  nearest  100  g)  was  determined
sing  a  SECA  220® digital  weight  scale  (Medical  Scales  and
easuring  Systems,  Hamburg,  Germany)  and  for  standing
eight  (in  centimeters  to  the  nearest  0.1  cm)  a  stadiometer
ncluded  in  the  same  equipment  was  used,  with  the  children
earing  only  undergarments.  Body  mass  index  was  calcu-
ated  based  on  the  formula:  BMI  =  (weight/height2).13 The
orld  Health  Organization  (WHO)  BMI  percentile  charts  were
n
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se  to  deﬁne  obesity  (if  BMI  >percentil  95;  normal  weight:
MI  between  percentil  5--85).
The  criteria  for  metabolic  syndrome  in  children  and
dolescents  were  deﬁned  according  to  the  International  Dia-
etes  Federation  concensus.14
lood  collection  and  biochemical  analysis
asting  venous  blood  samples  (15  mL)  were  obtained  to  esti-
ate  the  hematological  parameters.  Blood  specimens  were
ollected  in  vacutainer  tubes  with  or  without  ethylenedi-
minetetraacetic  acid  (EDTA)  as  needed.  Serum  and  plasma
ere  prepared  and  then  frozen  (−80 ◦C)  for  storage  until
nalysis.  High-sensitivity  C-reactive  protein  was  deter-
ined  by  immunonephelometry  from  serum  samples  and
rocessed  in  the  BN  ProSpec® System  (Siemens  Healthcare
iagnostics  Inc,  Munich,  Germany)  analyzer  (undetected  if
0.02  mg/dL).
Monocyte  chemoattractant  protein-1,  asymmetric
imethylarginine  and  E-selectin  were  determined  by  ELISA
sing  commercially  available  enzyme-linked  immunosor-
ent  assay  kits  OptEIATM (BD  Biosciences  Pharmingen,  CA,
SA).
Leptin  and  adiponectin  levels  were  determined  using
ommercially  available  enzyme-linked  immunosorbent  assay
its  (eBioscience  -- San  Diego,  CA,  United  States  and  BioVen-
or  -- Brno,  Czech  Republic,  respectively).
Insulin  levels  were  determined  by  chemiluminescence
rom  serum  samples  and  processed  in  the  IMMULITE  2000®
Siemens  Healthcare  Diagnostics  Inc,  Munich,  Germany)  ana-
yzer  and  glucose  levels  were  determined  from  plasma
amples  analyzed  in  the  VITROS  5.1  FS® (Ortho  Clinical  Diag-
ostics,  Johnson  &  Johnson,  NY,  USA)  system  by  microslide
echnology.
The  HOMA-IR  was  calculated  based  on  the  formula;
OMA-IR  =  insulin  (mU/L)  ×  glucose  (mmol/L)/22.5,  consid-
ring  3  as  the  cut-off  value  for  the  diagnosis  of  insulin
esistance.15
Total  cholesterol,  low-density  lipoprotein  cholesterol
LDL-C),  high-density  lipoprotein  cholesterol  (HDL-C),  and
riglyceride  (TG)  concentrations  were  measured  using  an
utomated  biochemical  analyzer  VITROS  5.1  FS® (Ortho  Clin-
cal  Diagnostics,  Johnson  &  Johnson,  NY,  USA).
For  determination  of  circulating  EPC  count,  peripheral
lood  (PB)  was  collected  in  EDTA  tubes,  stored  on  ice,
nd  processed  within  2  h.  Identiﬁcation  and  characteriza-
ion  of  circulating  EPC  was  performed  using  an  anti-CD146
onjugated  with  ﬂourescein  isothiocyanate  (clone:  P1H12,
ecton  Dickinson  (BD),  CA,  USA),  anti-KDR  conjugated  with
hycoeritrin  (clone:  89106,  R&D  System,  Headquarters,
inneapolis,  USA),  anti-CD34  peridinin  chlorophyll  pro-
ein  cyanine  5.5  (clone:  8G12,  BD  Bioscience,  CA,  USA),
nti-CD133  allophycocyanin  (clone:  293C3,  Miltenyi  Biotec,
ergisch  Gladbach,  Germany),  and  CD45  krome  orange
clone:  J.33,  Immunotech  --  Beckman  Coulter,  Marseille,
rance)  combination  of  monoclonal  antibodies  (mAb).
For  sample  staining,  a  direct  immunoﬂuorescence  tech-
ique  was  used.  Data  acquisition  was  performed  in  a
ACSCanto  II® ﬂow  cytometer  (BD  Biosciences  Pharmingen,
A,  USA)  using  the  FACSDiva® software  (BD  Biosciences
harmingen,  CA,  USA).  For  EPC  identiﬁcation,  the  modiﬁed
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International  Society  for  Hematotherapy  and  Graft  Engi-
neering  (ISHAGE)  sequential  gating  strategy  proposed  by
Schmidt--Lucke  was  followed.
Circulating  EPCS  were  identiﬁed  according  to  a  minimal
antigenic  proﬁle  that  includes  at  least  one  marker  of  stem-
ness/immaturity  (CD34  and  CD133),  plus  at  least  one  marker
of  endothelial  commitment  (KDR  and  CD146).  CD45  staining
was  used  to  exclude  leukocytes.
For  data  analysis,  the  InﬁnicytTM software,  V.1.5  (Cytog-
nos  SL,  Salamanca,  Spain)  was  used.
Statistical  analysis
The  data  was  analyzed  using  the  IBM  SPSS  20  software  (IBM
Corp.  Released  2011.  IBM  SPSS  Statistics  for  Windows,  NY,
USA).  The  descriptive  analysis  of  the  parametric  variables
was  done  by  calculating  the  mean  ±  standard  error  of  the
mean.  Student’s  t-test  and  Mann--Whitney  U  test  were  used
to  calculate  the  differences  in  the  demographic,  clinical,
and  hematological  parameters  between  the  obese  and  con-
trol  groups,  depending  on  the  normality  of  distribution.  For
categorical  response  variables,  differences  between  the  two
groups  were  assessed  using  the  chi-squared  test.  Logistic
regression  was  used  when  clinical  variables  were  con-
trolled  between  the  two  groups.  To  establish  the  correlation
between  the  parameters  in  the  obese  group,  Spearman’s  and
Pearsons’s  correlations  were  used.  The  results  were  consid-
ered  statistically  signiﬁcant  at  p  <  0.05.
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Table  1  Anthropometric,  clinical,  and  analytical  parameters  of  t
Variable  Obese  
n  Mean  ±  SEM  
Age  (years)  120  11.65  ±  0.43  
BMI  (kg/m2)  120  28.47  ±  0.44  
sBP  (mmHg)  120  116.60  ±  1.16  
dBP  (mmHg)  120  61.19  ±  0.69  
Leptin  (ng/mL)  118  28.97  ±  1.63  
Adiponectin  (g/mL)  95  3.60  ±  0.14  
Insulin  (UI/mL)  119  12.95  ±  0.73  
HOMA-IR  118  2.81  ±  0.17  
MCP-1  (pg/mL)  65  331.54  ±  46.49  
hsCRP (mg/dL)  118  0.2781  ±  0.03  
CT  (mg/dL)  120  166.86  ±  2.52  
HDL-C (mg/dL)  120  47.33  ±  0.90  
LDL-C  (mg/dL)  120  96.45  ±  2.44  
TG  (mg/dL)  120  82.71  ±  4.93  
ADMA  (mol/L)  76  0.44  ±  0.01  
E-selectin  (pg/mL) 77  12.8  ±  0.84  
EPCs  (numbers)  100  1,565,532.31  ±  56,764.76  
Male  n  (%) 120  61  (50.8%)  
BMI, body mass index; sBP, systolic blood pressure; dBP, diastolic b
resistance; MCP-1, monocyte chemoattractant protein-1; hsCRP, high-
density lipoprotein cholesterol; LDL-C, low density lipoprotein choleste
circulating endothelial progenitor cell count; NS, non-signiﬁcant p-valu
a Mann--Whitney U test.
b Student’s t-test.563
esults
omparative  analysis  between  the  obese  and
ontrol groups
ne  hundred  and  twenty  obese  children  and  adolescents,  61
oys  and  59  girls,  with  ages  between  6  and  17  years  (mean
ge  11.65  years  ±  2.96)  were  included  in  the  study.  The  con-
rol  group  was  made  up  of  41  healthy,  non-obese  children
nd  adolescents,  29  boys  and  12  girls,  within  the  same  age
roup  (mean  age  12.73  years  ±  2.77).
We  ﬁrstly  compared  the  two  group’s  anthropometric,
linical  and  analytical  parameters.  As  demonstrated  in
able  1, all  the  means  of  the  analyzed  parameters  were  sig-
iﬁcantly  higher  in  the  obese  group,  including  E-selectin,
DMA  and  circulating  EPCS,  except  for  adiponectin  and  HDL-
 (Fig.  1).  Total  cholesterol  and  monocyte  chemoattractant
rotein-1  showed  no  signiﬁcant  statistical  differences.
As  age  (p  =  0.038)  and  gender  (p  =  0.027)  were  signif-
cantly  different  between  the  two  groups,  the  analysis
as  repeated  using  logistic  regression,  and  the  results  did
ot  differ  signiﬁcantly,  namely,  MCP-1  (p  =  0.334),  ADMA
p  =  0.005),  E-selectin  (p  =  0.008),  and  EPCs  (p  =  0.043).  Total
holesterol  and  MCP-1  continued  to  show  no  signiﬁcant  dif-
erences.Circulating  EPC  count  were  directly,  but  weakly  corre-
ated,  to  BMI  (r  =  0.21;  p  =  0.016),  leptin  (  =  0.25;  p  =  0.006),
riglyceride  levels  (r  =  0.24;  p  =  0.031),  and  E-selectin
  =  0.30;  p  =  0.004).
he  obese  and  non-obese  groups.
Non-obese  p-value
n  Mean  ±  SEM
41  12.73  ±  0.27  0.038a
41  18.93  ±  0.43  <0.001b
41  107.77  ±  1.75  <0.001b
41  54.95  ±  1.41  <0.001a
41  4.85  ±  0.71  <0.001a
32  5.17  ±  0.41  <0.001a
33  7.32  ±  0.75  <0.001a
33  1.54  ±  0.15  <0.001a
31  304.53  ±  48.33  NS
40  0.05  ±  0.09  <0.001a
41  163.83  ±  5.39  NS
41  59.17  ±  2.04  <0.001a
41  82.71  ±  3.74  0.004b
41  59.15  ±  4.28  <0.001a
31  0.38  ±  0.02  0.005a
30  9.03  ±  0.92  0.003b
29  1,328,311.00  ±  64,449.43  0.007b
41  29  (70.7%)  0.027b
lood pressure; HOMA-IR, homeostasis model assessment-insulin
sensitivity C-reactive protein; CT, total cholesterol; HDL-C, high
rol; TG, triglycerides; ADMA, asymmetric dimethylarginine; EPCs,
e; n, sample number; SEM, standard error of the mean.
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Figure  1  Endothelial  progenitor  cell  count  in  the  obese  and
the non-obese  groups.  The  higher  levels  in  the  obese  group  may
reﬂect the  response  by  repairing  mechanisms  secondary  to  early
endothelial  activation.  Data  expressed  as  means  ±  standard
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 =  29.  *Student’s  t-test,  p  <  0.01  vs.  non  obese  group.
nalysis  of  the  obese  group
ody  mass  index  was  directly  and  moderately  correlated  to
CP-1  (  =  0.51;  p  <  0.001),  systolic  blood  pressure  (  =  0.47;
 <  0.001),  leptin  (  =  0.40;  p  <  0.001),  and  HOMA-IR  (  =  0.35;
 <  0.001);  weakly  correlated  to  hsCRP  (  =  0.22;  p  =  0.018);
nd  inversely  but  weakly  correlated  to  adiponectin
  =  −0.28;  p  =  0.007)  and  HDL-C  (  =  −0.26;  p  =  0.004).
Monocyte  chemoattractant  protein-1  was  directly  cor-
elated  to  systolic  blood  pressure  (  =  0.34;  p  =  0.005),  as
hown  in  Fig.  2.  High  sensitivity  C-reactive  protein  was
90.00
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igure  2  Correlation  between  monocyte  chemoattractant
rotein-1and  systolic  blood  pressure.  In  obesity,  cardiovascular
isk  factors  cluster  and  contribute  to  the  inﬂammatory  process,
s observed  in  the  correlation  between  systolic  blood  pressure
nd MCP-1  in  the  present  study.  sBP,  systolic  blood  pressure;
CP-1,  monocyte  chemoattractant  protein-1.
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eakly  correlated  to  leptin  (  =  0.32;  p  <  0.001)  and  LDL-C
  =  0.23;  p  =  0.011).
Systolic  blood  pressure  was  inversely  correlated  to
diponectin  (  =  −0.33;  p  =  0.001)  and  directly  correlated
o  HOMA-IR  (  =  0.23;  p  =  0.012)  and,  as  expected,  moder-
tely  correlated  to  age  (  =  0.50;  p  <  0.001).  Diastolic  blood
ressure  had  less  pronounced  correlations.
The  HOMA-IR  was  correlated  to  ADMA  (  =  0.34;  p  =  0.003)
roviding  the  most  direct  link  to  a  marker  of  endothe-
ial  activation.  This  was  evident  particularly  at  HOMA-IR
alues  above  3  (p  =  0.003),  the  cut-off  value  we  used
o  deﬁne  insulin  resistance.  It  was  also  directly  cor-
elated  to  leptin  (  =  0.39;  p <  0.001),  systolic  blood
ressure  (  =  0.23;  p  <  0.012),  and  diastolic  blood  pressure
  =  0.20;  p  <  0.033),  and  inversely  correlated  to  adiponectin
r  =  −0.21;  p  =  0.040).
Metabolic  syndrome  was  observed  in  11.7%  (n  =  14)
f  the  obese  patients.  As  expected,  being  part  of  the
eﬁnition,  systolic  (p  =  0.005),  but  not  diastolic  blood  pres-
ure  (p  =  0.728),  was  elevated,  as  were  triglyceride  levels
p  <  0.001),  HDL-C  was  lower  (p  =  0.007),  and  no  signiﬁcant
ifferences  were  observed  in  glucose  levels.  Regarding  the
arkers  of  endothelial  activation  and  repair  mechanisms,
DMA  was  directly,  but  weakly  correlated  to  E-selectin
  =  0.25;  p  =  0.046),  and  the  latter  was  weakly  correlated
o  circulating  EPC  count  (  =  0.22;  p  =  0.047).
iscussion
he  present  study  clearly  demonstrates  that,  unlike
heir  lean  counterparts,  obese  children  and  adolescents
ith  evidence  of  ongoing  low-grade  inﬂammation  and
ndothelial  activation  have  raised  EPC  count.  Correlations
etween  adiposity,  inﬂammatory  markers,  and  obesity-
elated  comorbidities  such  as  arterial  hypertension  and
nsulin  resistance  were  also  observed.
Monocyte  chemoattractant  protein-1  regulates  migration
nd  inﬁltration  of  monocytes  and  macrophages16 into  the
ascular  wall  and  plays  an  important  role  in  inﬂammation-
ediated  diseases,  such  as  obesity.17 As  scant  translational
esearch  has  been  done  in  this  ﬁeld,  the  authors  were  inter-
sted  in  evaluating  the  relationship  of  MCP-1  to  obesity
elated  comorbidities.  Unlike  the  ﬁndings  by  Breslin  et  al.,18
o  differences  were  observed  in  MCP-1  levels  between  the
bese  and  control  groups  nor  what  an  association  with  dys-
ipidemia  retrieved  (data  not  shown),  possibly  due  to  a
ifferent  sample  size  (39  obese  children  and  adolescents)
nd  ethnicity  (American-Mexican).  However,  in  the  obese
roup,  MCP-1,  unlike  hsCRP,  had  a  direct  correlation  with
ystolic  blood  pressure.  This  trend  was  not  found  in  the
ontrol  group.  It  is,  thus  tempting  to  postulate  that  in  child-
ood  obesity,  MCP-1  contributes  to  arterial  hypertension,
nd  implicitly  is  implicated  in  the  pathophysiological  mech-
nisms  leading  to  cardiovascular  disease  later  in  life.  Based
n  the  present  evidence,  MCP-1,  compared  to  hsCRP,  would
ppear  to  be  a  more  robust  cardiovascular  risk  marker.  How-
ver,  due  to  the  sample  size,  further  research  needs  to  be
one  in  this  ﬁeld.  To  the  best  of  the  authors’  knowledge,
hese  associations  have  not  been  previously  described.
The  prevalence  of  arterial  hypertension  in  childhood
aries  from  3%  to  5%.19 The  obese  group  had  signiﬁcantly
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higher  systolic  and  diastolic  blood  pressure  values  (p  <  0.001)
than  the  control  group.  The  prevalence  of  arterial  hyper-
tension  in  the  obese  group  was  9.2%,  and  almost  a  third
had  pre-hypertension  (26.7%).  Apart  from  MCP-1,  and  in
agreement  with  the  ﬁndings  by  Moser  et  al.,20 systolic  blood
pressure  was  directly  correlated  to  BMI  and  inversely  related
to  adiponectin  and  HDL-C.  This  cluster  of  mediators  cor-
relates  visceral  adiposity,  inﬂammation,  insulin  resistance,
and  hypertension,  some  of  the  components  of  the  metabolic
syndrome,  found  in  11.7%  of  the  obese  group.  A  particu-
lar  interesting  ﬁnding  was  the  inverse  correlation  between
adiponectin  and  arterial  hypertension,  thus  corroborating
the  ﬁndings  of  the  study  by  Brambilla  et  al.,21 in  which
adiponectin  was  proposed  as  one  of  the  mechanisms  related
to  hypertension  in  childhood  obesity.  This  implies  that  the
loss  of  its  antiatherogenic  and  anti-inﬂammatory  properties
contribute  to  the  underlying  mechanisms  of  obesity-related
hypertension.
Furthermore,  the  loss  of  adiponectin’s  insulin  sensitizing
properties  that  occurs  in  obesity  has  also  been  impli-
cated  in  insulin  resistance.22 Unlike  the  ﬁndings  by  Lee
et  al.,23 where  adiponectin  was  found  to  be  a  strong  inde-
pendent  predictor  of  insulin  sensitivity  in  obese  children
and  adolescents  of  different  racial  backgrounds,  in  the
present  study  adiponectin  was  shown  to  be  correlated  to
hyperinsulinaemia  (r  =  −0.23;  p  =  0.033),  but  not  to  insulin
resistance  (n  =  38%;  p  =  0.277),  despite  striking  differences
in  adiponectin  levels  between  the  obese  and  control  groups
(p  <  0.001).
The  present  study  included  only  white  subjects  from  a
different  geographical  area,  which,  together  with  the  sam-
ple  size  (n  =  45  with  HOMA-IR  >3),  might  account  for  the
observed  differences,  although  adiponectin  gene  polymor-
phisms  might  also  play  a  role.  This  hypothesis  is  merely
speculative,  as  it  was  not  tested  in  the  present  study.  How-
ever,  this  rationale  could  not  be  applied  to  leptin,  which
had  a  stronger  correlation  to  hyperinsulinaemia  (r  =  0.35;
p  <  0.001)  and  insulin  resistance  (p  <  0.001),  ﬁndings  in
accordance  with  previously  published  works.24 A  connection
between  MCP-1  (p  =  0.168),  hsCRP  (p  =  0.375),  and  insulin
resistance  was  not  observed.
The  authors  further  attempted  to  relate  ADMA  and  E-
selectin,  both  markers  of  endothelial  activation,  to  insulin
resistance.  In  adults,  raised  levels  of  asymmetric  dimethy-
larginine  are  considered  a  cardiovascular  risk  marker,  and  as
a  surrogate  of  nitric  oxide  bioavailability,  reﬂects  endothe-
lial  integrity.  A  direct  correlation  between  HOMA-IR  and
ADMA  (r  =  0.35;  p  =  0.003)  was  observed,  particularly  evi-
dent  in  the  insulin-resistant  group  (p  =  0.003),  ﬁndings  not
previously  reported.  Some  reports  have  suggested  that
ADMA  contributes  to  insulin  resistance  as  decreased  nitric
oxide  bioavailability  reduces  blood  ﬂow  to  insulin  sensi-
tive  tissues  compromising  glucose  uptake  in  response  to
insulin.25 Conversely,  insulin  resistance  itself  has  been  found
to  contribute  toward  endothelial  dysfunction.  Under  these
circumstances,  it  is  tempting  to  speculate  on  ADMA’s  per-
missive  role  on  the  interplay  between  insulin  resistance
and  endothelial  dysfunction,  through  its  actions  on  nitric
oxide  bioavailability.  A  direct  correlation  between  leptin
and  ADMA  was  also  observed,  but  only  in  girls.  This  is  not
surprising,  as  leptin  levels  were  signiﬁcantly  higher  in  obese
girls  (p  <  0.001).  Nevertheless,  this  ﬁnding,  not  previously
a
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eported,  potentially  links  leptin,  and  hence  adiposity,  to
ndothelial  activation.  Comparatively,  linear  regression  by
ogarithmic  transformation  showed  that  insulin  resistance
ad  a  greater  inﬂuence  on  ADMA.
E-selectin  is  a  speciﬁc  endothelial  adhesion  molecule
hose  levels  are  raised  in  endothelial  dysfunction,  promot-
ng  the  migration  of  inﬂammatory  cells  to  the  intima.  In  this
nalysis,  obese  children  and  adolescents  had  signiﬁcantly
igher  levels  than  healthy  controls,  implying  the  presence
f  endothelial  activation,  which  indicates  an  early  stage  of
therosclerosis.  Considering  the  entire  cohort,  a  direct,  but
eak  correlation  to  hsCRP  (  =  0.21;  p  =  0.033)  was  found,
einforcing  the  role  of  inﬂammation  in  endothelial  dys-
unction  and  in  agreement  with  published  literature,26 but
 similar  pattern  was  not  demonstrated  within  the  obese
roup,  possibly  due  to  its  homogeneity.  We  also  observed,
ithin  the  obese  group,  a  direct  correlation  between  ADMA
nd  circulating  EPC  count.  We  found  these  correlations
articularly  interesting  as  they  highlight  various  patho-
hysiological  pathways  related  to  endothelial  activation,
amely,  inﬂammatory  cell  adhesion  triggered  by  E-selectin,
ncreased  expression  of  ADMA,  who  competitively  inhibits
NOS,  reducing  nitric  oxide  bioavailability  and,  ultimately,
epair  of  injured  tissue  by  EPCS.  The  authors  believe  that
he  relationship  between  E-selectin  and  ADMA,  in  childhood
besity,  has  not  been  previously  published.
The  term  EPCs  should  be  reserved  for  a  progenitor  cell
estricted  speciﬁcally  to  the  endothelial  lineage.  In  1997,
sahara  et  al.27 reported  for  the  ﬁrst  time  on  the  exist-
nce  of  EPCs.  To  date,  no  speciﬁc  marker  has  been  found
o  clearly  identify  these  cells,  which  makes  their  isolation
ontroversial,  as  their  identiﬁcation  is  based  on  cell  surface
arkers  shared  by  other  hematological  cell  lines.  As  such
arious  methods  have  been  used  to  identify  EPCs.  In  order
o  minimize  false  positives  various  cell  surface  markers  have
een  integrated  to  identify  these  cells,  namely  those  linked
o  immature  cell  lines  (e.g.  CD34)  with  endothelial  commit-
ent  (e.g.  kinase  insert  domain  receptor).
As  reported  by  various  authors,  the  count  and  function
f  circulating  EPCS  not  only  correlate  inversely  with  cardio-
ascular  risk  factors,  but  also  may  predict  the  occurrence  of
ardiovascular  events,  particularly  in  the  adult  population.28
ata  regarding  EPCs  and  childhood  obesity  is  scarce.  A
eport  by  Jung  et  al. 29 observed  a  direct  correlation  to  E-
electin.  Contrary  to  the  present  study,  this  correlation  only
pplied  to  obese  adolescents.  In  the  present  study,  EPCs  and
-selectin  were  directly  correlated  in  the  pre-adolescent
bese  group,  a  ﬁnding  not  previously  reported  and  that  rein-
orces  the  fact  that  endothelial  dysfunction  is  present  in  very
oung  individuals.
In  this  analysis,  the  obese  group  had  a  signiﬁcantly  higher
umber  of  EPCs,  implying  that  elevated  EPCs  in  obese  chil-
ren  and  adolescents  represent  an  attempt  at  repairing
nderlying  vascular  damage.  Thus,  at  this  stage,  it  would
e  possible  to  reverse  the  underlying  endothelial  damage  if
teps  are  taken  to  control  weight.
The  main  strength  of  the  present  study  is  that  it  demon-
trates  that  obese  children  and  adolescents  are  potentially
t  risk  for  cardiovascular  events  during  early  adulthood
ue  to  the  presence  of  an  adverse  proatherogenic  proﬁle.
owever,  it  appears  that,  at  this  stage,  repairing  mecha-
isms  may  be  at  play  to  reverse  potentially  ongoing  vascular
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amage.  The  inference  is  that  therapeutic  interventions
imed  at  weight  loss  ought  to  be  aggressively  instituted  in
rder  to  reverse  endothelial  damage  and  obesity-related
omorbidities,  such  as  arterial  hypertension  and  insulin
esistance.
This  study  has  several  limitations.  Firstly  its  sample  size,
articularly  its  control  group.  It  also  only  included  a  white-
nly  population,  limited  to  a  particular  geographical  area,
he  former  due  to  local  race  distribution.  The  study  included
oth  genders,  as  well  as,  different  age  groups.  In  the  results,
hese  differences  were  adjusted  for,  and  therefore  their
nterference  was  nulliﬁed.
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